Frank Rimerman Advisors’s Insmed INSM Stock Holding History

Frank Rimerman Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,697	Closed	-$277K	–	631
2026 Q1	$277K	Buy	+1,697	New	+$261K	0.02%	517

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Frank Rimerman Advisors's INSM Position: Q2 2026 in Review

Frank Rimerman Advisors sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,697 shares — an estimated $277K sold.

Frank Rimerman Advisors first reported a position in INSM in Q1 2026 and held it in 1 quarter. The position peaked at $277K in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Frank Rimerman Advisors reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Frank Rimerman Advisors sold 1,697 Insmed shares in Q2 2026, an estimated $277K.
Frank Rimerman Advisors first reported a position in Insmed in Q1 2026 and held it in 1 quarter.
Frank Rimerman Advisors's Insmed position peaked at $277K in Q1 2026.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.